Anti-drug antibodies to brolucizumab and ranibizumab in serum and vitreous of patients with ocular disease.
Acta Ophthalmol
; 100(8): 903-910, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35225432
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Eye Diseases
/
Ranibizumab
Limits:
Humans
Language:
En
Journal:
Acta Ophthalmol
Journal subject:
OFTALMOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Alemania